3Shape A/S
$2.0K 1 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
VoxNeuro USA Inc.
VoxNeuro USA Inc. reported $2,000.00 across General Payments, Research, and Ownership to 1 physicians and teaching hospitals across 1 transactions.
- $2.0K Below-median payer
- All-tracks total
- 1 Below-median volume
- Transactions
- 1 Below-median reach
- Recipients
- #1799
- of 1,925 companies
VoxNeuro USA Inc. reported $2,000.00 across all CMS Open Payments tracks (General + Research + Ownership) to 1 physicians and teaching hospitals in Program Year 2024 - ranking #1799 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $2,000.00, averaging $2.0K per recipient.
VoxNeuro USA Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
10/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer voxneuro-usa-inc VoxNeuro USA Inc.
$2.0K · #1799/1,925 · 0.0% industry · PY2024
- TOT $2.0K
- RANK #1799
- SHARE 0.0%
- TXN 1
- RCP 1
- CAT 1
- GEN $2.0K
- TOP1 100.0%
- PY 2024
Volume peers
Nearest volume peer: 3Shape A/S ($2.0K)
VoxNeuro USA Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for VoxNeuro USA Inc.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For VoxNeuro USA Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
1 transactions worth $2.0K make "Consulting Fee" the top general-payment category in the 1-category breakdown below, 100.0% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Consulting Fee" leads VoxNeuro USA Inc.'s 1-category general-payment breakdown at $2.0K, 100.0% of the reported total.
How VoxNeuro USA Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $2.0K | 1 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $2,000.00 (100.0%) of $2,000.00 in this company's General Payments records across 1 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for VoxNeuro USA Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Mark Hallett
$2,000.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
VoxNeuro USA Inc. ranks #1799 of 1,925 by total payments (bottom 7% by spend) but is notably more concentrated than that alone would suggest -- #130 of 1,838 by HHI (top 7% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- SiteSaver Inc. : $4.3K total payments, HHI 10000
- Elekta Solutions AB : $2.4K total payments, HHI 10000
- Substrate HD : $72.2K total payments, HHI 10000
- TightLine Development, LLC : $750.0K total payments, HHI 10000
- New Wave Endo-Surgical Corp. : $1.2K total payments, HHI 10000
- Ottobock SE & Co. KGaA : $306.0K total payments, HHI 10000
- VoxNeuro USA Inc. (this company) : $2.0K total payments, HHI 10000
- Solco Biomedical Co., Ltd. : $50.0K total payments, HHI 10000
- PAVmed Inc. : $2.8K total payments, HHI 10000
- Advanced Instruments, LLC : $3.1K total payments, HHI 10000
- Xiros Limited : $2.6K total payments, HHI 10000
- Arena Pharmaceuticals, Inc. : $34.1K total payments, HHI 10000
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as VoxNeuro USA Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about VoxNeuro USA Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with VoxNeuro USA Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Evergreen Orthopedic Research Lab LLC
$2.0K 1 recipients
Compare payment profiles
Facet Technologies LLC
$2.0K 1 recipients
Compare payment profiles
LINA Medical USA Inc
$2.0K 3 recipients
Compare payment profiles
Medivance, Inc.
$2.0K 1 recipients
Compare payment profiles
Athena Bioscience, LLC
$2.0K 142 recipients
Compare payment profiles
Put this to use
VoxNeuro USA Inc. ranks #1799 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just VoxNeuro USA Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.